Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

Stiff to Dilate and Risky to Cut Through: Iliac Radiation Arteritis

Published:

15 June 2020

Citation:

Vascular & Endovascular Review 2020;3:e06.

BEST-CLI Trial

Published:

19 May 2020

Citation:

Vascular & Endovascular Review 2020;3:e05.

Wearable Technologies and Telemonitoring for Vascular Disease

Published:

24 April 2020

Citation:

Vascular & Endovascular Review 2020;3:e04.

Thrombosis Following Endovenous Glue Ablation

Published:

20 March 2020

Citation:

Vascular & Endovascular Review 2020;3:e03.